Autologous Stem-Cell Transplantation for Severe Scleroderma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

1. Emerging Cell-Based Therapies for Systemic Sclerosis: From Stem Cells to CAR-T Cells.Current issues in molecular biology · 2026
   Review
2. [S2k guidelines on diagnostics and treatment of systemic sclerosis : Full version].Zeitschrift fur Rheumatologie · 2025
   Review
3. New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.Annals of neurology · 2025
   Review
4. Chimeric antigen receptor T cell therapy for autoimmune disease.Nature reviews. Immunology · 2024
   Review
5. Juvenile Scleroderma.Indian journal of pediatrics · 2024
   Review
6. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.Cells · 2022
   Review
7. Fat transplantation induces dermal adipose regeneration and reverses skin fibrosis through dedifferentiation and redifferentiation of adipocytes.Stem cell research & therapy · 2022
   Article
8. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).Bone marrow transplantation · 2022
   Review
9. Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.Rheumatology (Oxford, England) · 2022
   Article
10. Dental implants in patients suffering from systemic sclerosis: a retrospective analysis of clinical outcomes in a case series with 24 patients.International journal of implant dentistry · 2021
    Article
11. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.Bone marrow transplantation · 2021
    Review
12. Systemic sclerosis (scleroderma): remaining challenges.Annals of translational medicine · 2021
    Review
13. Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all.Therapeutic advances in musculoskeletal disease · 2021
    Review
14. [Autologous hematopoietic stem cell transplantation for autoimmune diseases : Current indications and mode of action, a review on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)].Zeitschrift fur Rheumatologie · 2020
    Review
15. Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.Trends in immunology · 2019
    Review
16. Immunotherapy of systemic sclerosis.Human vaccines & immunotherapeutics · 2018
    Article

Corrections and comments

• Comment on
  Autologous Stem-Cell Transplantation for Severe Scleroderma.2018

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as